Skip to main content

Table 1 Characteristics of the study population (n = 1040) at blood draw and study entry

From: Hormonal determinants of mammographic density and density change

Characteristic

No.

Mean (SD) or %

 Age at blood draw, years

1040

57.9 (9.3)

 BMI at study entry, kg/m2

1040

25.3 (4.0)

 Age at menarche, years

1016

13.2 (1.5)

 Ever use of contraceptives, %

1028

83.9

 Number of births, n

1039

1.9 (1.1)

 Age at first birth, years

921

26.8 (5.2)

 Postmenopausal, n

705

67.8

 Age at menopause, years

371

49.6 (5.4)

 Alcohol consumption, g/day

1035

6.9 (8.3)

 Physical activity, MET-h/d

1040

42.4 (6.4)

 Previous use of MHT, %

1040

24.4

 Mammographic features

  

  Mammographic density, dense area, cm2

1040

24.9 (22.2)

  Mammographic density change, dense area, cm2/year

1040

− 0.8 (3.3)

Circulating hormones

 

Median (SD)

 Progestogens

  Pregnenolone, ng/mL

718

5.3 (10.2)

  Progesterone, ng/mL

905

3.9 (22.4)

  17OH-progesterone, ng/mL

910

2.1 (11.4)

 Androgens

  DHEA, ng/mL

768

22.0 (45.2)

  DHEAS, μg/mL

974

1.8 (2.2)

  Androstenedione, ng/mL

817

4.8 (24.6)

  Testosterone, ng/mL

829

2.0 (11.1)

  Free testosterone, pg/mL

824

46.6 (312.0)

  Androsterone, ng/mL

711

13.1 (17.0)

  Etiocholanolone, ng/mL

654

6.1 (10.4)

 Oestrogens

  Oestrone, ng/mL

450

6.3 (21.5)

  Oestrone sulphate, ng/mL

938

7.1 (21.3)

 Corticoids

  Corticosterone, ng/mL

915

4.1 (14.4)

  Aldosterone, ng/mL

565

0.8 (2.5)

  11-Deoxycortisol, ng/mL

866

3.2 (15.1)

  Cortisol, ng/mL

914

128.8 (61.7)

  Cortisone, ng/mL

909

44.7 (35.1)

 Peptide hormones and proteins

  Prolactin, ng/mL

1035

15.4 (14.2)

  SHBG, μg/mL

1034

4.1 (2.4)

  1. BMI body mass index, DHEA dehydroepiandrosterone, DHEAS dehydroepiandrosterone sulphate, MET metabolic equivalent of task, MHT menopausal hormone therapy, SD standard deviations, SHBG sex hormone-binding globulin